SOLAGE Side Effects

6535171-4 | Skin Hyperpigmentation
on Oct 19, 2009 Female patient from UNITED STATES , 67 years of age, was treated with Solage (View Usage). Patient experienced the following unwanted or unexpected effects: skin hyperpigmentation. Solage dosage: .

6535170-2 | Skin Hyperpigmentation
Patient was taking Solage (View Usage). Patient had the following side effects: skin hyperpigmentation on Sep 11, 2009 from UNITED STATES Additional patient health information: Female patient , 67 years of age, . Solage dosage: .

6535169-6 | Skin Hyperpigmentation
Adverse event was reported on Jun 25, 2009 by a Female patient taking Solage (View Usage) (Dosage: ) . Location: UNITED STATES , 63 years of age, After Solage was administered, patient had the following side effects: skin hyperpigmentation.

6535168-4 | Application Site Bleeding, Application Site Discolouration, Application Site Erythema, Application Site Pain, Application Site Reaction, Application Site Scab
on Apr 14, 2009 Female patient from UNITED STATES , 55 years of age, was diagnosed with skin hyperpigmentation and was treated with Solage (View Usage). Patient experienced the following unwanted or unexpected effects: application site bleeding, application site discolouration, application site erythema, application site pain, application site reaction, application site scab. Solage dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PURICAN (View Purican Review and Purican Label ).


6535166-0 | Application Site Pain
on Mar 23, 2009 Female patient from UNITED STATES , 55 years of age, was diagnosed with lentigo and was treated with Solage (View Usage). Patient had the following side effects: application site pain. Solage dosage: .

6535164-7 | Application Site Erythema, Dermatitis, Product Quality Issue, Swelling Face
Patient was taking Solage (View Usage). After Solage was administered, patient had the following side effects: application site erythema, dermatitis, product quality issue, swelling face on Oct 06, 2009 from UNITED STATES Additional patient health information: Male patient , 62 years of age, . Solage dosage: .

6235982-9 | No Therapeutic Response
Adverse event was reported on Jun 17, 2009 by a Female patient taking Solage (View Usage) (Dosage: Application 2 Daily Top) was diagnosed with lentigo and. Location: UNITED STATES , 67 years of age, weighting 195.0 lb, Patient experienced the following unwanted or unexpected effects: no therapeutic response.

5779755-X | Acute Promyelocytic Leukaemia, Hypotension, Hypoxia, Ileal Perforation, Peritonitis, Retinoic Acid Syndrome, Somnolence, Tachycardia, Tachypnoea
on Jun 04, 2008 Male patient from INDIA , 19 years of age, was treated with Solage (View Usage). Patient had the following side effects: acute promyelocytic leukaemia, hypotension, hypoxia, ileal perforation, peritonitis, retinoic acid syndrome, somnolence, tachycardia, tachypnoea. Solage dosage: . During the same period patient was treated with ALL TRANSRETINOIC ACID (ATRA)(TRETINOIN) (View All-transretinoic Acid (atra)(tretinoin) Review and All-transretinoic Acid (atra)(tretinoin) Label ). Patient was hospitalized.

5605584-3 | C-reactive Protein Increased, Eschar, Haemoglobin Decreased, Inflammation, Lethargy, Pain, Platelet Count Decreased, Scrotal Ulcer, Staphylococcal Infection
on Jan 11, 2008 Male patient from TUNISIA , 31 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Solage (View Usage). After Solage was administered, patient had the following side effects: c-reactive protein increased, eschar, haemoglobin decreased, inflammation, lethargy, pain (What is pain?), platelet count decreased, scrotal ulcer, staphylococcal infection (What is staphylococcal infection?). Solage dosage: . During the same period patient was treated with ALL TRANSRETINOIC ACID (ATRA) (TRETINOIN) (45 Mg/m2, Qd) (View All-transretinoic Acid (atra) (tretinoin) Review and All-transretinoic Acid (atra) (tretinoin) Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ). Patient was hospitalized.

5308327-6 | Acute Febrile Neutrophilic Dermatosis, Petechiae
Patient was taking Solage (View Usage). Patient experienced the following unwanted or unexpected effects: acute febrile neutrophilic dermatosis, petechiae on Apr 06, 2007 from UNITED STATES Additional patient health information: Male patient , 19 years of age, was diagnosed with acute promyelocytic leukaemia and. Solage dosage: . During the same period patient was treated with TRETINOIN (View Tretinoin Review and Tretinoin Label ).

4855743-2 | Application Site Irritation, Application Site Reaction, Nausea, Swelling Face
Adverse event was reported on Dec 15, 2005 by a Female patient taking Solage (View Usage) (Dosage: As Directed 2 Times A Day Topical , 3 Doses) . Location: UNITED STATES , 72 years of age, weighting 112.0 lb, Patient had the following side effects: application site irritation, application site reaction, nausea (What is nausea?), swelling face. During the same period patient was treated with THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ), PREMARIN (View Premarin Review and Premarin Label ).

4631451-8 | Application Site Reaction, Mental Disorder, Vitiligo
on Mar 24, 2005 Male patient from , 74 years of age, was diagnosed with lentigo and was treated with Solage (View Usage). After Solage was administered, patient had the following side effects: application site reaction, mental disorder, vitiligo. Solage dosage: Qd.